Indapamida Slavia

Indapamide, the active ingredient in Indapamida Slavia, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower high blood pressure and to reduce fluid retention in conditions such as heart failure and renal disease.

GNH USA supplies Indapamida Slavia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable lead times and comprehensive after‑sales support.

Indapamide is indicated for conditions that involve elevated blood pressure or fluid overload, acting as a diuretic and antihypertensive agent.

Hypertension: reduces peripheral vascular resistance and plasma volume, leading to sustained lowering of systolic and diastolic blood pressure. Edema associated with heart failure: increases urinary sodium and water loss, helping to relieve pulmonary and peripheral congestion in chronic heart failure patients. Edema associated with renal disease: facilitates fluid removal in nephrotic syndrome or chronic kidney disease, decreasing peripheral edema and improving symptom control.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Electrolyte imbalance (e.g., low potassium): may cause mild dizziness, muscle cramps, or fatigue due to altered potassium levels. - Increased urination: patients often experience a frequent need to void, especially during the first weeks of therapy. - Headache: a mild to moderate intensity headache may occur, typically transient and responsive to simple analgesics. - Dry mouth or thirst: sensation of reduced salivation leading to increased thirst and discomfort.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss can lead to hypotension, dizziness, and in extreme cases, syncope. - Acute kidney injury: sudden decline in renal function may present with elevated creatinine and reduced urine output. - Allergic reactions: rash, pruritus, or angioedema may develop, requiring immediate medical attention. - Blood dyscrasias: leukopenia or thrombocytopenia can occur, presenting with increased infection risk or bleeding tendencies.

When prescribing Indapamide, clinicians should consider several precautionary measures to minimize risk.

Renal function: assess baseline creatinine and monitor during therapy. Electrolytes: check serum potassium and sodium before initiation and periodically. Hypotension: monitor blood pressure, especially in patients also receiving other antihypertensives. Gout: use cautiously in patients with a history of gout, as uric acid levels may rise. Pregnancy and lactation: avoid unless benefits outweigh potential risks, due to limited safety data. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Indapamide can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Lithium: concomitant use may increase lithium serum concentrations, raising the risk of lithium toxicity and neurological symptoms. - NSAIDs: may blunt indapamide’s natriuretic effect and impair renal perfusion, reducing diuresis. - ACE inhibitors or ARBs: combined therapy can cause excessive reduction in blood pressure and may precipitate acute kidney injury, especially in volume‑depleted patients.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive antihypertensive effect may cause symptomatic hypotension; monitor blood pressure and adjust doses